[Appropriate use of antibiotics in hospitals. Investigating clinical practices in management of community-acquired pneumonia]

Presse Med. 2005 Dec 17;34(22 Pt 1):1687-95. doi: 10.1016/s0755-4982(05)84252-6.
[Article in French]

Abstract

Introduction: The rationalization of medical practices for antibiotic use in hospitals is necessary to improve both the cost-efficiency and effectiveness of health care. This study sought to investigate the impact of implementation of local management guidelines for inpatient community-acquired pneumonia (CAP).

Methods: This retrospective, comparative study measured the quality of antibiotic prescriptions with the 10-item Medication Appropriateness Index (MAI). Clinical and demographic characteristics, as well as process-of-care and outcome indicators, were recorded for all patients with CAP admitted to a medical ward at the Nantes university hospital during two 12-month periods: before (Period A, 39 patients) and after (Period B, 50 patients) implementation of local guidelines.

Results: The MAI was significantly higher during period B than period A (5.1 points compared with 2.2, p=0.0001). Guideline implementation shortened the mean duration of antibiotic treatment (13.1 versus 16.0 days, p=0.0003) and of intravenous treatment (3.4 versus 4.7 days, p=0.04). The mean duration of hospital stay also fell substantially (7.4 versus 15.0 days, p=0.0001), as did the mean cost of antibiotics (35.4 versus 64.1 euros, p=0.003).

Discussion: The MAI confirmed that antimicrobial practices varied significantly and that appropriate local guidelines improved the quality of antibiotic prescriptions and saved hospitalization costs.

Conclusion: The MAI, which assesses the appropriateness of antibiotic use in hospitals, could be an interesting tool for prospective use as an indicator of quality-of-care improvement and for more efficient use of available health care resources.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / economics
  • Anti-Bacterial Agents / therapeutic use*
  • Community-Acquired Infections / drug therapy*
  • Drug Utilization / statistics & numerical data*
  • Female
  • France
  • Guideline Adherence
  • Humans
  • Length of Stay / statistics & numerical data
  • Male
  • Pneumonia, Bacterial / drug therapy*
  • Practice Guidelines as Topic
  • Quality Assurance, Health Care
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents